According to the research report titled ‘Global Proteomics Market - Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery, Others), End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)‘, available with Market Study Report, global proteomics market was valued at USD 3.49 billion in 2020 and is slated to record significant growth over 2021-2026.

Soaring R&D expenditure, rising popularity of nano proteomics, as well as technological advancements in the field are catalyzing the growth of global proteomics market. Additionally, developments in mass spectrometry-based proteomics, rewarding prospects pertinent to biomarker identification, and inclination for personalized medications are propelling the industry expansion.

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4026313/

Elaborating on the negatives, high costs associated with components, stringent regulatory directives as well as lack of skilled professionals are likely to hamper the industry growth over the projected timeframe.

In terms of component, worldwide proteomics market is divided into services, reagents, and instruments, whereas based on application scope, the industry space is categorized into drug discovery, clinical diagnostic, and others. With respect to end user terrain, the market sphere is classified into labs & clinics, and hospitals.
 

From a regional point of view, North America held 50.32% industry share in 2020 and is slated to grow momentously through 2026, owing to rising popularity and adoption of personalized medicines, favorable government initiatives and funding, and increasing demand of high-quality research tools to reproduce data. Also, investment inflow for developing structure-based drug design and presence of renowned players are positively swaying the industry dynamics in North America.
 

Prominent companies in global proteomics market include Bio-Rad Laboratories Inc., Danaher Corporation, Agilent Technologies Inc., GE Healthcare, WuXi AppTec, The Merck Group, Thermo Fisher Scientific, QIAGEN N.V., Eurofins, Bruker Corporation, and Promega Corporation among others.